Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Source study found

Story checked

Xenon-based method measures key MRI contrast metal more sensitively than earlier techniques (opens in a new tab)

medicalxpress.com · 2026-10-29

Short answerEvidenceSource

Short answer

Not supported

Not supported.

The study does not answer the story's main claims.

  • 4 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Not supported

The study doesn't address any of the story's claims. We found the paper, but it doesn't report the details the story leads with.

  • 4 not covered
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

4 claims in this story

Showing all 4 claimsChoose a verdict to focus the list.

Claim 1 of 4Not coveredThe study describes a xenon-based method for measuring gadolinium more sensitively than earlier MRI techniques.View evidenceHide evidence

As statedmore sensitively than earlier techniques

Why this verdict

The abstract-level profile supports a novel 129Xe HyperCEST NMR competition assay for detecting free Gd3+ via signal changes, but it does not provide comparative sensitivity data, limits of detection, or benchmarking against earlier MRI/NMR techniques. The headline claim that the method is more sensitive than earlier techniques therefore outruns what can be verified from the abstract.

1

Study evidence

A cryptophane-A monoacid host–guest competition assay produces detectable changes in 129Xe HyperCEST NMR signals when free Gd3+ is present in solution.

“Detection of Gd 3+ via HyperCEST NMR in a competition assay using cryptophane-A monoacid”
Claim 2 of 4Not coveredThe team says gadolinium concentrations in the micromolar range can be measured with the method.View evidenceHide evidence

As statedmicromolar range

Why this verdict

The profile supports detection of free Gd3+ in solution using the assay, but explicitly notes that the abstract provides no quantitative sensitivity, detection-limit, dynamic-range, or concentration-range metrics. The micromolar-range measurement claim cannot be verified at abstract depth.

1

Study evidence

A cryptophane-A monoacid host–guest competition assay produces detectable changes in 129Xe HyperCEST NMR signals when free Gd3+ is present in solution.

“Detection of Gd 3+ via HyperCEST NMR in a competition assay using cryptophane-A monoacid”
Claim 3 of 4Not coveredThe researchers used hyperpolarized xenon in a cage molecule, where gadolinium displaces the xenon and reduces the xenon signal.View evidenceHide evidence

Why this verdict

The abstract-level profile supports use of a cryptophane-A monoacid host with 129Xe HyperCEST in a competition assay, and it supports that free Gd3+ produces changes in the xenon HyperCEST signal. However, the more specific mechanism and direction stated by the story—that gadolinium displaces xenon from its cage and reduces or eliminates the xenon signal—are not detailed in the supplied abstract-level evidence.

1

Study evidence

A cryptophane-A monoacid host–guest competition assay produces detectable changes in 129Xe HyperCEST NMR signals when free Gd3+ is present in solution.

“Detection of Gd 3+ via HyperCEST NMR in a competition assay using cryptophane-A monoacid”
Claim 4 of 4Not coveredThe authors suggest the method could help distinguish free gadolinium from chelated forms and improve detection of gadolinium-containing substances in the environment.View evidenceHide evidence

Why this verdict

The abstract-level profile supports detection of free Gd3+ in solution and frames the work as a novel indirect NMR method for gadolinium ion detection. It does not verify application to distinguishing free versus chelated gadolinium in practice, clinical use, or environmental detection in complex matrices. The story’s hedging helps, but the specific translational applications are not verifiable from the abstract.

1

Study evidence

A cryptophane-A monoacid host–guest competition assay produces detectable changes in 129Xe HyperCEST NMR signals when free Gd3+ is present in solution.

“Detection of Gd 3+ via HyperCEST NMR in a competition assay using cryptophane-A monoacid”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • The evidence is from an in vitro/in-solution analytical chemistry experiment, not from clinical, living-human, biological-system, or environmental-sample validation.

    The story mentions that the method was tested under experimental conditions, but its framing emphasizes possible clinical and environmental tracking/detection without clearly stating that the abstract-level evidence is limited to solution experiments and lacks validation in complex matrices.

    From in vitro HyperCEST competition assay

2 things the story did carry across
  • The paper’s central contribution is an in-solution 129Xe HyperCEST NMR competition assay using a cryptophane-A monoacid host to detect free Gd3+ through changes in HyperCEST signals.
  • The abstract-level profile does not report validation against orthogonal methods or testing for specificity/interference by other ions.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

1

Evidence read

study summary

Lead result

in vitro

1Lead resultin vitroDemonstrate an indirect NMR (129Xe HyperCEST) competition assay using a cryptophane-A monoacid host to detect the presence of free Gd3+ in solution via changes in HyperCEST signals.in vitro HyperCEST competition assayExpand

In plain English

In vitro study reporting a competition assay that uses a cryptophane-A monoacid host together with 129Xe HyperCEST NMR spectroscopy to reveal the presence of free Gd3+ in solution; the presence of free Gd3+ is reported to produce changes in the 129Xe HyperCEST signal, described as a novel indirect NMR-based detection approach for gadolinium ions.

Key findings

  • A cryptophane-A monoacid host–guest competition assay produces detectable changes in 129Xe HyperCEST NMR signals when free Gd3+ is present in solution.
“Detection of Gd 3+ via HyperCEST NMR in a competition assay using cryptophane-A monoacid”
What this piece can’t prove
  • Summary and findings are based solely on the article abstract provided; full experimental details and data are not available in the supplied text.

2 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Open the paper in Tessa

Detection of Gd 3+ via HyperCEST NMR in a competition assay using cryptophane-A monoacid

Sensors & Diagnostics · 2026

Source record (opens in a new tab)

Why this one

Near certain

NewsLink found the paper. Tessa is where you inspect it deeply.

Papers considered

The selected paper, plus nearby candidates.

Crossref, Europe PMC, PubMed · 31 candidate papers

Selected

Detection of Gd 3+ via HyperCEST NMR in a competition assay using cryptophane-A monoacid

Sensors & Diagnostics · 2026 · Crossref

Source (opens in a new tab)
Candidate

Author response for "Toward Point-of-Care Cancer Diagnostics: Gold Nanoparticle-Based Colorimetric Sensors"

2026 · Crossref

Source (opens in a new tab)

And 25 more candidates considered.